August 07th, 2023
Toronto, Canada. (August 07, 2023) Benetech Inc. is a software development company that creates and markets tools for use in prenatal screening. Its flagship product, Benetech PRA™ is used by hundreds of leading hospitals and labs around the world to screen millions of pregnancies each year.
Benetech is pleased to announce today the release of Benetech PRA version 4.0.
Benetech PRA 4.0 includes many enhancements to the software. This new major release version of PRA expands screening capabilities by enabling Pre-eclampsia screening. It also contains several new features necessary for labs to perform screening with up-to-date parameters while continuing to be customizable and compatible with any workflow.
Pre-eclampsia screening in PRA 4.0 utilizes maternal factors and biomarkers to identify pregnancies at high risk for developing the condition. Patients can then receive treatment and monitoring to reduce adverse outcomes. Further enhancements in PRA 4.0 include updated algorithm options with the introduction of SURUSS 2013 parameters, enhanced sonographer management and monitoring tools, and the ability to activate pre-alerts (comments prior to interpretation) or post-alerts (comments added to reports).
“This milestone release proves Benetech’s commitment to maintaining and developing quality clinical software solutions for our clients” said Les Hansen, President of Benetech Inc., “It contains a number of enhancements for better screening application—now with Pre-eclampsia screening—in addition to the many added features to improve lab efficiency.”
Upgraded Benetech PRA 4.0 is available as a free download to all Benetech customers with a current Annual User Service Contract in place. PRA 4.0 will be gradually released and accessible for clients based on global regions.
Note, Pre-eclampsia screening is not a default option in PRA 4.0, please contact Benetech for details.
Benetech PRA 4.0 continues to carry a Class 2 medical device license under Health Canada and is certified by UL to ISO 13485:2016 and MDSAP. CE mark as per IVDR 2017/746 is currently pending.
Customers interested in upgrading their PRA version can contact the company at firstname.lastname@example.org for assistance.
1 800 253 8611
About Benetech Inc.
Located in Toronto Canada, Benetech was founded in 1987 and has been privately owned and operated ever since. Benetech PRA is used by some of the leading hospitals and labs in the world and is considered a gold standard for prenatal screening. The quality systems of Benetech Inc. have been registered by UL LLC. to ISO 13485:2016. More information on Benetech Inc. and its products can be found at www.benetech.com or by contacting email@example.com.